1-s2.0-s0006291x03006673-main

Upload: rachel-dias

Post on 03-Apr-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 1-s2.0-S0006291X03006673-main

    1/3

    Copper-induced oxidation of epinephrine: protective effect ofDD-DAHK,

    a synthetic analogue of the high affinity copper

    binding site of human albumin

    Angela Roberts,a David Bar-Or,a,b,* James V. Winkler,b and Leonard T. Raela,b

    a Department of Trauma Research, Swedish Medical Center, 501 E. Hampden Avenue, Englewood, CO 80110, USAb DMI BioSciences Inc., 3601 South Clarkson Street #420, Englewood, CO 80110-3944, USA

    Received 2 April 2003

    Abstract

    Epinephrine is known to be rapidly oxidized during sepsis. Ischemia and acidosis, which often accompany sepsis, are associated

    with the release of weakly bound cupric ions from plasma proteins. We investigated whether copper promotes oxidation of epi-

    nephrine at both physiological and acidic pH and whether DD-AspDD-AlaDD-HisDD-Lys (DD-DAHK), a human albumin (HSA)

    N-terminus synthetic peptide with a high affinity for cupric ions, attenuates this oxidation. Epinephrine alone [100 lM] or with

    CuCl2 [10 lM], and with CuCl2 [10 lM] and DD-DAHK [20 lM] at pH 7.4, 7.0, 6.5, and 6.0 were incubated for 1 h at 37 C. Epi-

    nephrine oxidation was measured by the spectrophotometric quantification of its oxidation product, adrenochrome. We found that

    adrenochrome increased, suggesting copper-induced oxidation of epinephrine. At pH 7.4, 7.0, 6.5, and 6.0, adrenochrome increased

    by 47%, 53%, 24%, and 6% above baseline, respectively. DD-DAHK attenuated the copper-induced oxidation of epinephrine to

    baseline levels. These in vitro results indicate that copper-induced epinephrine oxidation is greatest at the physiological pH 7.4 as

    well as in severe acidosis, pH 7.0, and that DD-DAHK completely inhibits this oxidation.

    2003 Elsevier Science (USA). All rights reserved.

    Keywords: Epinephrine; Adrenaline; Sepsis; Ischemia; Acidosis; Copper;DD-AspDD-AlaDD-HisDD-Lys; DAHK; Human albumin

    Sepsis is the most common cause of mortality in the

    ICU, with a mortality rate of 3040% in all sepsis pa-

    tients and reaching as high as 80% in patients with septic

    shock [1]. Despite recent advances in the treatment of

    sepsis, mortality remains very high [2,3]. Sepsis is char-

    acterized by a decline in blood pressure and a resistance

    to vasoconstrictor therapy [4,5]. Epinephrine is rapidly

    oxidized during sepsis to adrenochrome [6]. The rapidoxidation of epinephrine prevents its action as a vaso-

    constrictor and adrenochrome itself has been shown to

    be cardiotoxic [710].

    Copper has been reported to promote the in vitro

    oxidation of catecholamines, including epinephrine [11

    13]. General or localized acidosis, which occurs in sepsis

    and other illnesses [14,15], results in the release of copper

    from ceruloplasmin and other proteins in the circulation

    [1618]. Previous studies in our laboratory have dem-

    onstrated that copper inhibits the anticoagulant activity

    of activated protein C which is used to treat sepsis [19]. In

    the present study, we sought to determine whether cop-

    per-induced oxidation of epinephrine is pH dependent in

    physiological ranges and, if so, whether the introduction

    of the human albumin N-terminus, DD-AspDD-AlaDD-

    HisDD-Lys (DD-DAHK), which has a high affinity for

    cupric ions, will protect epinephrine from oxidation. Theresults of this in vitro experiment showed that after

    60 min of incubation, the oxidation of epinephrine was

    increased twofold when copper was present at pH 7.4

    and 7.0 but had little effect at pH 6.0 and 6.5. However,

    at all pH tested, the addition of DD-DAHK inhibited the

    oxidation of epinephrine to levels at or below baseline.

    Experimental procedures

    Materials. The human albumin N-terminus analogue, DD-DAHK,

    was synthesized by Bowman Research (Newport, Wales, UK).

    Biochemical and Biophysical Research Communications 304 (2003) 755757

    www.elsevier.com/locate/ybbrc

    BBRC

    * Corresponding author. Fax: 1-303-788-4064.

    E-mail address: [email protected] (D. Bar-Or).

    0006-291X/03/$ - see front matter 2003 Elsevier Science (USA). All rights reserved.

    doi:10.1016/S0006-291X(03)00667-3

    http://mail%20to:%[email protected]/http://mail%20to:%[email protected]/
  • 7/28/2019 1-s2.0-S0006291X03006673-main

    2/3

  • 7/28/2019 1-s2.0-S0006291X03006673-main

    3/3

    (Englewood, CO). We thank Richard Shimonkevitz, PhD, and Greg-

    ory Thomas, BS, for their technical assistance in this research.

    References

    [1] H.N. Holmes (Ed.), Handbook of Infectious Diseases, Spring-

    house Corporation, Danvers, MA, 2000.

    [2] M.M. Parker, J.E. Parrillo, Septic shock: hemodynamics and

    pathogenesis, JAMA 250 (1984) 33243327.

    [3] Centers for Disease Control, Increase in national hospital

    discharge survey rates for septicemiasUnited States 19791987,

    Morb. Mortal. Wkly. Rep. 39 (1990) 3134.

    [4] T.J. Evans (Ed.), Septic ShockMethods and Protocols, Humana

    Press, Totowa, NJ, 2000.

    [5] R.A. Balk, R.C. Bone, The septic syndrome. Definition and

    clinical implications, Crit. Care Clin. 5 (1989) 18.

    [6] H. Macarthur, T.C. Westfall, D.P. Riley, T.P. Misko, D.

    Salvemini, Inactivation of catecholamines by superoxide gives

    new insights on the pathogenesis of septic shock, Proc. Natl.

    Acad. Sci. USA 97 (2000) 97539758.

    [7] G. Behonick, M. Novak, E. Nealley, S. Baskin, Toxicology update:

    the cardiotoxicity of the oxidative stress metabolites of catechol-

    amines (aminochromes), J. Appl. Toxicol. 21 (2001) S15S22.

    [8] N.S. Dhalla, J.C. Yates, B. Naimark, K.S. Dhalla, R.E. Beamish,

    B. Ostadal, in: J. Daniel Acosta (Ed.), Cardiovascular Toxicity,

    Raven Press, New York, 1992, p. 239.

    [9] A. Bindoli, D.J. Deeble, M.P. Rigobello, L. Galzigna, Direct and

    respiratory chain-mediated redox cycling of adrenochrome, Bio-

    chim. Biophys. Acta 1016 (3) (1990) 349356.

    [10] P.K. Singal, K.S. Dhillon, R.E. Beamish, N. Kapur, N.S. Dhalla,

    Myocardial cell damage and cardiovascular changes due to i.v.

    infusion of adrenochrome in rats, Br. J. Exp. Pathol. 63 (2) (1982)

    167176.

    [11] T.P. Ryan, D.M. Miller, S.D. Aust, The role of metals in the

    enzymatic and nonenzymatic oxidation of epinephrine, J. Bio-

    chem. Toxicol. 8 (1) (1993) 3339.[12] M.P. Rigobello, G. Scutari, R. Boscolo, A. Bindoli, Oxidation of

    adrenaline and its derivatives by S-nitrosoglutathione, Nitric

    Oxide 5 (1) (2001) 3946.

    [13] F. Remiao, M. Carvalho, H. Carmo, F. Carvalho, M.L. Bastos,

    Cu2-induced isoproterenol oxidation into isoprenochrome in

    adult rat calcium-tolerant cardiomyocytes, Chem. Res. Toxicol.

    15 (6) (2002) 861869.

    [14] J.C. Rodrigues, A.M. Fein, in: A.M. Fein, et al. (Eds.), Diagnostic

    Approach and Clinical Manifestations of Severe Sepsis, Sepsis and

    MultipleOrganFailure, Williams & Wilkins, Baltimore,MD, 1987.

    [15] B.A. Mizock, J.L. Falk, Lactic acidosis in critical illness, Crit.

    Care Med. 20 (1992) 8093.

    [16] E. Berenshtein, B. Mayer, C. Goldber, N. Kitrossky, M. Chevion,

    Patterns of mobilization of copper and iron following myocardial

    ischemia: possible predictive criteria for tissue injury, J. Mol. Cell.

    Cardiol. 29 (1997) 30253034.

    [17] U. Srinivas, J.H. Braconier, B. Jeppsson, M. Abdulla, B. Akesson,

    P.A. Ockerman, Trace element alterations in infectious diseases,

    Scand. J. Clin. Lab. Invest. 48 (1988) 495500.

    [18] B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic

    metal ions in human disease: an overview, Methods Enzymol. 186

    (1990) 185.

    [19] D. Bar-Or, L.T. Rael, J.V. Winkler, R.L. Yukl, G.W. Thomas,

    R.P. Shimonkevitz, Copper inhibits activated protein c: protective

    effect of human albumin and an analogue of its high-affinity

    copper-binding site, DD-DAHK, Biochem. Biophys. Res. Commun.

    290 (2002) 13881392.

    [20] M.C. Linder, C.A. Goode, Biochemistry of Copper, Plenum Press,

    New York, 1991.

    [21] D.J. Lamb, D.S. Leake, Acidic pH enables caeruloplasmin to

    catalyze the modification of low-density lipoprotein, FEBS Lett.

    338 (1994) 122126.

    [22] A.G. Morell, I.H. Scheinberg, Preparation of an apoprotein from

    ceruloplasmin by reversible dissociation of copper, Science 127

    (1958) 588590.

    [23] S.M. Cobbe, P.A. Poole-Wilson, The time of onset and severity of

    acidosis in Myocardial ischemia, J. Mol. Cell. Cardiol. 12 (1980)

    745760.

    [24] D. Bar-Or, L.T. Rael, E.P. Lau, K.R.R. Nagaraja, G.W. Thomas,

    J.V. Winkler, R.L. Yukl, R.G. Kingston, C.G. Curtis, An analog

    of the human albumin N-terminus protects against copper-

    induced in vitro oxidative stress, Biochem. Biophys. Res. Com-

    mun. 284 (2001) 856862.

    [25] H. Macarthur, D.M. Couri, G.H. Wilken, T.C. Westfall, A.J.

    Lechner, G.M. Matuschak, Z. Chen, D. Salvemini, Modulation ofserum cytokine levels by a novel superoxide dismutase mimetic,

    M40401, in an Escherichia colimodel of septic shock: correlation

    with preserved circulating catecholamines, Crit. Care Med. 31 (1)

    (2003) 237245.

    [26] D.E. Taylor, A.J. Ghio, C.A. Piantadosi, Reactive oxygen species

    produced by liver mitochondria of rats in sepsis, Arch. Biochem.

    Biophys. 316 (1) (1995) 7076.

    A. Roberts et al. / Biochemical and Biophysical Research Communications 304 (2003) 755757 757